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Abstract Testing differences between a treatment and
control group is common practice in biomedical research
like randomized controlled trials (RCT). The standard
two-sample t-test relies on null hypothesis significance
testing (NHST) via p-values, which has several draw-
backs. Bayesian alternatives were recently introduced
using the Bayes factor, which has its own limitations.
This paper introduces an alternative to current Bayesian
two-sample t-tests by interpreting the underlying model
as a two-component Gaussian mixture in which the ef-
fect size is the quantity of interest, which is most rel-
evant in clinical research. Unlike p-values or the Bayes
factor, the proposed method focusses on estimation un-
der uncertainty instead of explicit hypothesis testing.
Therefore, via a Gibbs sampler the posterior of the ef-
fect size is produced, which is used subsequently for
either estimation under uncertainty or explicit hypoth-
esis testing based on the region of practical equivalence
(ROPE). An illustrative example, theoretical results
and a simulation study show the usefulness of the pro-
posed method, and the test is made available in the R
package bayest.
Keywords Bayesian t-test · Reproducibility in
medical research · Region of practical equivalence
(ROPE)
1 Introduction
In medical research, the t -test is one of the most pop-
ular statistical procedures conducted. In randomized
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controlled trials (RCT), the goal often is to test the ef-
ficacy of new treatments or drugs and find out the size
of an effect. Usually, a treatment and control group are
used, and differences in a response variable like blood
pressure or cholesterol level between both groups are
observed. The gold standard for deciding if the new
treatment or drug is more effective than the status quo
treatment or drug is the p-value, which is the prob-
ability, under the null hypothesis H0, of obtaining a
difference equal to or more extreme than what was ac-
tually observed. The dominance of p-values when com-
paring two groups in medical (and other) research is
overwhelming [19], [20], [25].
The original two-sample t-test belongs to the class
of frequentist solutions. These are based on sampling
statistics, which allow to reject the null hypothesis via
the use of p-values. The misuse and drawbacks of p-
values in medical research have been detailed in a va-
riety of papers, including an official ASA statement in
2016 [32]. On the other side, Bayesian versions of the
two-sample t-test have become more popular recently.
Examples include the proposals in [13], [28], [34], [31]
and [15]. All of these focus on the Bayes factor (BF)
for testing a null hypothesis H0 : δ = 0 of no effect
against a one- or two-sided alternative H1 : δ > 0,
H1 : δ < 0 or H1 : δ 6= 0. Bayes factors themselves are
also not without problems: (1) Bayes factors are sensi-
ble to prior modeling [18]; (2) Bayes factors require the
researcher to calculate marginal likelihoods, the calcu-
lations of which can be complex except when conjugate
distributions exist; (3) In the setting of the two-sample
t-test, Bayes factors weight the evidence for H0 : δ = 0
against the evidence for H1 : δ 6= 0 (or H1 : δ < 0,
or H1 : δ > 0) given the data x. In the case when
BF10 = 20, H1 is 20 times more likely after observ-
ing the data than H0. The natural question following
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in such cases is: How large is δ? A Bayes factor cannot
answer this question and was not designed to answer
such questions, but often this is of most relevance in
applied biomedical research. Last, in most applied re-
search, estimation of the effect size δ is more desirable
than a mere rejection or acceptance of a point or com-
posite hypothesis [19], [20], [22].
To be fair enough, Bayes factors can be computed
alongside posterior estimates, so testing and estimation
do not mutually exclude each other. As the Bayes factor
is often proposed as a replacement for the p-value, it is
even more questionable if practitioners will really com-
bine testing with estimation of effect sizes, especially
when scales translating the size of a Bayes factor into
evidence (similar to p < .05, p < .01) are regularly pro-
vided by now, see [7] and [2]. p-values and the Bayes
factor are a useful tools if explicit hypothesis testing is
necessary. However, exactly this necessity may be ques-
tioned in a wide range of applied biomedical research.
Therefore, this paper proposes an alternative Bayesian
two-sample t-test by formulating the statistical model
as a two-component Gaussian mixture with known al-
locations and using the region of practical equivalence
(ROPE). Instead of focussing on rejection or confirma-
tion of hypotheses, the proposed method’s focus lies on
estimation of the effect size under uncertainty.
2 Method
2.1 Modeling the Bayesian t-test as a mixture model
with known allocations
In this section, the two-sample t-test is modelled as a
two-component Gaussian mixture with known alloca-
tions.
“Consider a population made up of K subgroups,
mixed at random in proportion to the relative
group sizes η1, ..., ηK . Assume interest lies in some
random feature Y which is heterogeneous across
and homogeneous within the subgroups. Due to
heterogeneity, Y has a different probability dis-
tribution in each group, usually assumed to arise
from the same parametric family p(y|θ) however,
with the parameter θ differing across the groups.
The groups may be labeled through a discrete in-
dicator variable S taking values in the set {1, ...,K}.
When sampling randomly from such a popula-
tion, we may record not only Y , but also the
group indicator S. The probability of sampling
from the group labeled S is equal to ηS, whereas
conditional on knowing S, Y is a random vari-
able following the distribution p(y|θS) with θS be-
ing the parameter in group S. (...) The marginal
density p(y) is obviously given by the following
mixture density
p(y) =
K∑
S=1
p(y, S) = η1p(y|θ1) + ...+ ηKp(y|θK)
” [10, p. 1]
Clearly, this resembles the situation of the two-sample
t-test, in which the allocations S are known. While
traditionally mixtures are treated with missing alloca-
tions, in the setting of the two-sample t-test these are
known, leading to a “degenerate” mixture1. While this
assumption does not only remove computational dif-
ficulties like label switching, it also makes sense from
a semantic perspective: the inherent assumption of a
researcher is that the population is indeed made up
of K = 2 subgroups, which differ in a random fea-
ture Y which is heterogeneous across groups and ho-
mogeneous in each group. The group indicator S of
course is recorded. When conducting a randomized con-
trolled trial (RCT), the clinician will choose the pa-
tients according to a sampling plan, which could be
set to achieve equally sized groups, that is, η1 = η2.
Therefore, when sampling the population with the goal
of equally sized groups, the researcher samples the ob-
jects with equal probability from the population. After
the RCT is conducted, the resulting histogram of ob-
served Y values will take the form of the mixture den-
sity p(y) above and express bimodality due to the mix-
ture model of the data-generating process.2 After fixing
the mixture weights, the family of distributions for the
single groups needs to be chosen. The above considera-
tions lead to consider finite mixtures of normal distribu-
tions, as these ‘occur frequently in many areas of applied
statistics such as [...] medicine’ [10, p. 169]. The com-
ponents p(y|θi) become fN (y;µi, σ2i ) for i = 1, ...,K
in this case, where fN (y;µi, σ
2
i ) is the density of the
univariate normal distribution. Parameter estimation
in finite mixtures of normal distributions consists of
estimation of the component parameters (µi, σ
2
i ), the
allocations Si, i = 1, ..., n and the weight distribution
(η1, ..., ηK) based on the available data yi, i = 1, ..., n.
In the case of the two-sample Bayesian t-test, the al-
locations Si (where Si = 0 if yi belongs to the first
component and Si = 1 else) are known for all observa-
tions yi, i = 1, ..., n. Also, the weights η1, η2 are known.
1 The mixture is called degenerate here, because when allo-
cations are known, the likelihood is not mixed in the classical
sense.
2 If unbalanced groups are the goal, the weights could be
adjusted accordingly. As in most cases equally sized groups
are considered, η1 = η2 = 0.5 is a justified assumption re-
garding the sampling process in the study or experiment con-
ducted, when balanced groups are used.
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Therefore, inference is concerned with the component
parameters µk, σ
2
k given the complete data S, y.
Definition 1 (Bayesian two-sample t-test model)
Let S, Y be random variables with S taking values in
the set {1, 2} and Y in R. If Y |S = i ∼ N (µi, σ2i ) for
i = 1, 2, so conditional on S the component densities of
Y are Gaussian with unknown parameters µi and σ
2
i ,
and if the marginal density is a two-component Gaus-
sian mixture with known allocations
p(y) = η1fN (y;µ1, σ
2
1) + η2fN(y;µ2, σ
2
2)
where η2 :=
1
n
∑n
i=1 1Si=1(yi, Si) and η1 = 1 − η2, the
complete data S, Y follow the Bayesian two-sample t-
test model.
2.2 Inference via Gibbs Sampling
From the above line of thought it is clear that due to
the representation via a mixture model with known al-
locations, no prior is placed directly on the effect size
δ := µ1−µ2s itself, where
s :=
√
(n1 − 1)s21 + (n2 − 1)s
2
2
n1 + n2 − 2
and s21 and s
2
2 are the empirical variances of the two
groups, see also Cohen [5]. This is the common ap-
proach in existing Bayesian t-tests [15]. Instead, in the
proposed mixture model, priors are assigned to the pa-
rameters of the Gaussian mixture components µ1, µ2
and σ21 , σ
2
2 . This has several benefits: Incorporation of
available prior knowledge is easier achieved with the
mixture component parameters than for the effect size,
which is an aggregate of these component parameters.
Consider a drug where from biochemical properties it
can safely be assumed that the mean in the treatment
group will become larger, but the variance will increase,
too. Incorporating such knowledge on µi and σi is much
easier than incorporating it in the prior of the effect size
δ. This situation holds in particular, when group sizes
n1, n2 are not balanced.
These practical gains of translating prior knowledge
into prior parameters comes at a cost: In contrast to
existing solutions [15], the model implies that no closed
form expression for the posterior of δ is available. There-
fore, sampling methods are used here, to first construct
the joint posterior p(µ1, µ2, σ1, σ2|S, y) and subsequently
use a sample
(µ
(1)
1 , µ
(1)
2 , σ
(1)
1 , σ
(1)
2 , ..., µ
(m)
1 , µ
(m)
2 , σ
(m)
1 , σ
(m)
2 )
of size m, to produce a sample (δ(1), δ(2), ..., δ(m)) of δ,
where δ(i) :=
µ
(i)
1 −µ
(i)
2
s(i)
and
s(i) =
√
(n1 − 1)(s
(i)
1 )
2 + (n2 − 1)(s
(i)
2 )
2
n1 + n2 − 2
In summary, via Gibbs sampling the posterior of δ can
be approximated reasonably well. In order to apply
Gibbs sampling, the conditional distributions need to
be derived.
2.3 Derivation of the full conditionals using the
independence prior
To derive the full conditionals, it first has to be decided
which priors should be used on the mixture compo-
nent parameters. There are multiple priors available,
the most prominent among them the conditionally con-
jugate prior and the independence prior [8,?]. While the
conditionally conjugate prior has the advantage of lead-
ing to a closed-form posterior p(µ, σ2|S, y), the main
difficulty in the setting of the Bayesian two-sample t-
test is that while a priori the component parameters
θk = (µk, σ
2
k) are pairwise independent across both
groups, inside each group the mean µk and variance
σ2k are dependent. This is in contrast to the assump-
tion in the setting of the Bayesian two-sample t-test,
and therefore the independence prior is chosen, which
is used in [8] and [26]. The independence prior assumes
the mean µk and the variance σ
2
k are a priori indepen-
dent, that is p(µ, σ2) =
∏K
k=1 p(µk)
∏K
k=1 p(σ
2
k), with
µk ∼ N (b0, B0) and σ2k ∼ IG(c0, C0), where IG(·) is
the inverse Gamma distribution. The normal prior on
the means µk seems reasonable as the parameters b0
and B0 can be chosen to keep the influence of the prior
only weakly informative.3 The inverse Gamma prior is
chosen because for a two-component Gaussian mixture
to show any signs of bimodality – in which case one
would assume differences between two subgroups in the
whole sample – the variance should not be huge, be-
cause otherwise the modes (or the bell-shape) of the
two normal-components of the mixture will flatten out
more and more, until unimodality is reached. Thus, the
inverse Gamma prior connects this model aspect by giv-
ing more probability mass to smaller values of σ2k, while
extremely large values get much less prior probability
mass.4 The hyperparameters c0 and C0 then offer con-
3 Another option would be a tn prior, but this would also
imply another free hyperparameter to be estimated simulta-
neously, the degrees of freedom n.
4 Another option would be an exponential prior with pa-
rameter λ, but as the exponential distribution is just a spe-
cial case of the gamma distribution, the more general gamma
prior is selected here.
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trol over this kind of shrinkage on σ2k towards zero. In
the simulation study below the prior sensitivity will also
be studied briefly.
The independence prior is therefore used and leads
to the following full conditionals:
Theorem 1 For the Bayesian two-sample t-test model,
the full conditional distributions under the independence
prior
p(µ, σ2) =
K∏
k=1
p(µk)
K∏
k=1
p(σ2k)
with µk ∼ N (b0, B0) and σ2k ∼ IG(c0, C0) (where IG(·)
is the inverse Gamma distribution) are given as:
p(µ1|µ2, σ
2
1 , σ
2
2 , S, y) = p(µ1|σ
2
1 , S, y) ∼ N (b1(S), B1(S))
p(µ2|µ1, σ
2
1 , σ
2
2 , S, y) = p(µ2|σ
2
2 , S, y) ∼ N (b2(S), B2(S))
p(σ21 |µ1, µ2, σ
2
2 , S, y) = p(σ
2
1 |µ1, S, y) ∼ IG(c1(S), C1(S))
p(σ22 |µ1, µ2, σ
2
1 , S, y) = p(σ
2
1 |µ1, S, y) ∼ IG(c2(S), C2(S))
with B1(S), b1(S), B2(S), b2(S) as defined in equations
(22) and (23), and c1(S), c2(S), C1(S) and C2(S) as
defined in equations (24) and (25) in the Appendix A.2.
A proof is given in Appendix A.2, which builds on the
derivations in Appendix A.1. Note that when η1 6= η2,
N1(S) and N2(S) in the Appendices just need to be
changed accordingly. For example, if the first group con-
sists of 30 observations, and the second group of 70,
setting N1(S) = 30 and N2(S) = 70 implies η1 = 0.3
and η2 = 0.7, handling the case of unequal group sizes
easily.
2.4 Derivation of the single-block Gibbs sampler
Based on the full conditionals derived in the last sec-
tion, this section now derives a single-block Gibbs sam-
pler to obtain the joint posterior distribution
p(µ1, µ2, σ
2
1 , σ
2
2 |S, y)
given the complete data (S, y). The resulting Gibbs
sampler is given as follows:
Corollary 1 (Single-block Gibbs sampler for the
Bayesian two-sample t-test) The joint posterior dis-
tribution
p(µ1, µ2, σ
2
1 , σ
2
2 |S, y)
in the Bayesian two-sample t-test model can be simu-
lated under the independence prior as:
Conditional on the classification S = (S1, ..., SN):
1. Sample σ2k in each group k, k = 1, 2 from an inverse
Gamma distribution G−1(ck(S), Ck(S))
2. Sample µk in each group k, k = 1, 2, from a normal
distribution N (bk(S), Bk(S))
where Bk(S), bk(S) and ck(S), Ck(S) are given by equa-
tions (22), (23), (24) and (25) in the Appendix.
A proof is given in Appendix A.3.
2.5 The shift from hypothesis testing to estimation
under uncertainty and the ROPE
As already mentioned, instead of explicit hypothesis
testing via p-values and Bayes factors, we follow the
proposed shift from hypothesis testing to estimation
under uncertainty. Cumming [6] proposed such a shift
originally from frequentist hypothesis testing to estima-
tion, called the ’New Statistics’, a process observable
in a broad range of scientific fields, see Wasserstein &
Lazar [33]. Note that one of the six principles for prop-
erly interpreting p-values in the 2016 ASA-statement
stressed that a p-value “does not measure the size of
an effect or the importance of a result.” [32, p. 132].
Cumming [6] therefore included in his proposal a fo-
cus on “estimation based on effect sizes” [6, p. 7]. To
promote this shift, Kruschke & Liddell [22] offered two
conceptual distinctions, which are replicated in table 1
below.
While Cumming [6] originally proposed a shift from
frequentist hypothesis testing to frequentist estimation
under uncertainty, we propose that this shift can be
achieved easier by Bayesian methods. The main rea-
sons are that confidence intervals as quantities for es-
timation are still “highly sensitive to the stopping and
testing intentions.” [22, p. 184], while Bayesian poste-
rior distributions are not, see also Berger & Wolpert [1,
Chapter 4].
Table 1 Two conceptual distinctions in the practice of data
analysis, replicated from Kruschke & Liddell [22]
Frequentist Bayesian
Hypothesis
test
p-value (null
hypothesis signifi-
cance test)
Bayes factor
Estimation
with uncer-
tainty
MLE with CI
(The “New
Statistics”)
Posterior Dis-
tribution with
highest posterior
density interval
(HPD)
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2.6 The proposal of a region of practical equivalence
To facilitate the shift to an estimation-oriented perspec-
tive, Kruschke & Liddell [22] advertised the region of
practical equivalence (ROPE). As they note: ‘ROPE’s
go by different names in the literature, including “in-
terval of clinical equivalence”, “range of equivalence”,
“equivalence interval”, “indifference zone”, “smallest
effect size of interest,” and “good-enough belt” ...’ [22,
p. 185], where these terms come from a wide spectrum
of scientific domains, see Carlin & Louis [3], Freedman,
Lowe and Macaskill [9], Hobbs & Carlin [17], Lakens
[23] and Schuirmann [29]. The uniting idea is to estab-
lish a region of practical equivalence around the null
value of the hypothesis, which expresses “the range of
parameter values that are equivalent to the null value for
current practical purposes.” [22, p. 185]. With a cau-
tion not to slip back into dichotomic black-and-white
thinking, the following decision rule was proposed by
Kruschke & Liddell [22]: Reject the null value, if the
95% highest posterior density interval (HPD) falls en-
tirely outside the ROPE. Accept the null value, if the
95% HPD falls entirely inside the ROPE. In the first
case, with more than 95% probability the parameter
value is not inside the ROPE, and therefore not prac-
tically equivalent to the null value. A rejection of the
null value then seems legitimate. In the second case, the
parameter value is inside the ROPE with at least 95%
posterior probability, and therefore practically equiva-
lent to the null value. It seems legitimate to accept the
null value. Of course, it would also be possible to accept
the null value iff the whole posterior is located inside
the ROPE, leading to an even stricter decision rule.
While the idea of a ROPE is intriguing, a limitation
should be noted which is that it can only apply in situa-
tions where scientific standards of practically equivalent
parameter values exist and are widely accepted by re-
searchers. Luckily, this is the case for effect sizes, which
have a long tradition of being categorised in biomedical
and psychological research, see Cohen [5].
Definition 2 (ROPE) The region of practical equiv-
alence (ROPE) R for (or around) a hypothesis H ⊂ Θ
is a subset of the parameter space Θ with H ⊂ R.
A statistical hypothesis H is now described via a re-
gion of practical equivalence R, e.g. H : δ = δ0 can be
described as R := [δ0 − ε, δ0 + ε] for ε > 0. By defini-
tion, any set R ⊂ Θ with H ⊂ R is allowed to describe
H , and should be selected depending on how precise
the measuring process of the experiment or study is as-
sumed to be. Next, we define two options for the ROPE:
Definition 3 (Correctness) Let R ⊂ Θ a ROPE
around a hypothesis H ⊂ Θ, that is H ⊂ R, where
H makes a statement about the unknown model pa-
rameter θ. If the true parameter value θ0 lies in R, that
is θ0 ∈ R, then R is called correct, otherwise incorrect.
A correct ROPE therefore contains the true parameter
value θ0, while an incorrect one does not.
2.7 The proposal for a shift towards estimation under
uncertainty
The two major drawbacks of the proposal of Kruschke
[21] and Kruschke & Liddell [22] are that the ROPE
still facilitates hypothesis testing, enforcing a binary
decision of rejection or acceptance, while it is also un-
clear what to do when the 95%-HPD lies partly inside
and partly outside the ROPE. Therefore, a different
proposal is made in this paper, which is estimation of
the mean probable effect size (MPE) instead of hypoth-
esis testing. This procedure will be used in the proposed
t-test afterwards. First, the acceptance or rejection of
a hypothesis H can be formalized as follows:
Definition 4 (α-accepted / α-rejected) Let θ the
unknown parameter (or vector of unknown parameters)
in an experiment E := {X, θ, {fθ}}, where the random
variable X taking values in R and having density fθ for
some θ ⊂ Θ, is observed. Let f(θ|x) the posterior distri-
bution of θ (under any prior pi(θ)), and let Cα the cor-
responding α% highest density interval of f(θ|x). Let
R ⊂ Θ a ROPE around the hypothesis H of interest,
which makes a statement about θ. Then, if Cα ⊂ R,
the hypothesis H is called α-accepted, else α-rejected.
If α = 1, then H is simply called accepted, else rejected.
Thus, if Cα lies completely inside the ROPE R and if
α = 1, the entire posterior probability mass indicates
that θ is practically equivalent to the values described
by the ROPE R. Thus, H can be accepted. If α < 1,
the strength of this statement becomes less with de-
creasing α of course. For example, if H is 0.75-accepted
for a given ROPE R, 25% of the posterior indicate that
θ may take values different than the ones included in the
ROPE R. It is clear that little is gained if the value of α
is small or close to zero when speaking of α-acceptance.
Therefore, instead of forcing an acceptance or rejection
(which only makes sense for substantial values of α), a
perspective focussing on continuous estimation is pre-
ferred:
Definition 5 (Posterior mass percentage) Let f(θ|x)
a posterior for θ and δMPE := E[θ|x] the mean posterior
effect size (where the expectation E is taken with re-
spect to the posterior). Let R1, ..., Rm be a partition of
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the support of the posterior f(θ|x) into different ROPEs
corresponding to different hypothesesH1, ..., Hm, which
make statements about the unknown parameter (vec-
tor) θ. Without loss of generality, let Rj the ROPE for
which δMPE ⊂ Rj , j ⊂ {1, ...,m}. The posterior mass
percentage PMPRj (δMPE) of δMPE is given as
PMPRj (δMPE) :=
∫
Rj
f(θ|x)dθ
that is, the percentage of the posterior distribution’s
probability mass inside the ROPE Rj around δMPE .
For simplicity of notation, the subscript Rj is omitted
whenever it is clear which ROPEs Rj are used for parti-
tioning the support of f(θ|x). Now, in contrast to strict
α-acceptance or α-rejection rules based on the ROPE
Rj , we propose to use δMPE and PMP (δMPE) together
to estimate the effect size δ under under uncertainty,
and to quantify this uncertainty via PMP (δMPE). If
δMPE is non-zero, the t-test found a difference between
both groups. The size of this difference is quantified by
δMPE itself. The uncertainty in this statement is quan-
tified by PMP (δMPE). For the developed two-sample
t-test, we propose the following procedure:
1. For a fixed credible level α, the effect size range
(ESR) should be reported. That is, which effect sizes
δ are assigned positive probability mass by the α%
HPD interval, 0 ≤ α ≤ 1. The ESR is a first estimate
of credible effect sizes a posteriori.
2. The support of the posterior distribution f(δ|S, Y )
in the Bayesian t-test model is partitioned into the
standardized ROPEs of the effect size δ of [5], lead-
ing to a partition P of the support as given in the
definition of PMP (δMPE).
3. The mean posterior effect size δMPE is calculated
as an estimate of the true effect size δ. The sur-
rounding ROPE Rj with δMPE ⊂ Rj of the par-
tition P is selected, and the exact percentage in-
side Rj is reported as the posterior mass percentage
PMP (δMPE).
The above procedure leads to an estimation of the effect
size δ under uncertainty instead of a hypothesis testing
perspective. Additionally to the posterior mean δMPE ,
the posterior mass percentage PMP (δMPE) gives a
continuous measure of the trustworthiness of the es-
timate ranging from 0% to 100% (actually from zero to
one, but for better interpretability how much of the pos-
teriors mass is allocated in the ROPERj the values zero
to 100 percent will be used in what follows). δMPE es-
timates with PMP (δMPE) > 0.5 (or 50%) could be in-
terpreted as decisive, but do not need to. PMP (δMPE)
can be treated as a continuous measure of support for
the effect size estimated by δMPE . There are multiple
advantages of utilising a ROPE and combining it with
δMPE and PMP (δMPE), the most important of which
may be:
Theorem 2 Let Rj ⊂ Θ a ROPE around δMPE , that
is δMPE ⊂ Rj. If Rj is correct, then PMP (δMPE)→ 1
for n → ∞ almost surely, and if Rj is incorrect, then
PMP (δMPE) → 0 for n → ∞ almost surely, except
possibly on a set of pi-measure zero for any prior pi on
θ.
A proof is given in Appendix A.4. Using δMPE together
with PMP (δMPE) therefore will eventually lead to the
correct estimation of δ in the sense that when a cor-
rect ROPE is chosen, the posterior mass percentage
will converge to one, and if an incorrect ROPE is cho-
sen, the posterior mass percentage will converge to zero.
Thus, the procedure indicates whether δ is practically
equivalent to the values given by the ROPE or not. If
necessary, explicit hypothesis testing can be performed
via α-rejection. The advantages compared to p-values
and Bayes factors which favour an explicit hypothesis
testing perspective are:
1. As [14, p. 338] stress with regard to the dichotomy
induced by hypothesis testing, ‘estimation of the
size of effects and the uncertainty surrounding our
estimates will be far more important for scientific
inference and sound judgment than any such classi-
fication.’
2. In contrast to the Bayes factor (BF) the ROPE and
δMPE have important advantages: they do not en-
courage the same automatic calculation routines as
Bayes factors. For example, [12] warned explicitly
against Bayes factors becoming the new p-values
due to the same automatic calculation routines, and
the approach via the ROPE fosters estimation and
judging the evidence based on the continuous sup-
port for δMPE provided by PMP (δMPE), instead
of using thresholds.
3. The ROPE is supported by the following argument,
which questions the use of testing point hypothesis
like H0 : δ = 0 (no matter if rejecting or confirm-
ing is the goal): In practice, measuring is always
done with finite precision (like blood pressure, or
the heart rate), and therefore the goal rarely is to
show (or reject) that the effect size δ is exactly equal
to zero, but much more that δ is negligibly small to
deny the existence of any existing, (clinically) rel-
evant effect. Therefore, invariances like δ = 0 can
be interpreted as not existing, at least not exactly,
and the search for approximate invariances, as de-
scribed by a ROPE R = (−.2, .2) around δ = 0 is
intellectually (more) compelling. A clinician will be
satisfied by the statement that the true effect size is
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not exactly zero, but with 95% probability negligi-
bly small.
2.8 Illustrative example
To clarify the above line of thought, the following ex-
ample combines the developed Gibbs sampler for the
Bayesian t-test with the ROPE, δMPE and PMP (δMPE).
It uses data from Wagenmakers et al. [30], who con-
ducted a randomized controlled trial in which partici-
pants had to fill out a personality questionnaire while
rolling a kitchen roll clockwise or counter-clockwise.
The mean score of both groups was compared after-
wards. A traditional two-sided two-sample Welch’s t-
test indicates that there is no significant difference be-
tween both groups, yielding a p-value of 0.4542.5 What
is missing is the effect size, which is of much more inter-
est. Note that computing the effect size from the raw
study data does not quantify the uncertainty in the
data, which is undesirable. From the p-value, a clini-
cian can only judge that the results are unlikely to be
observed under the null hypothesis. However, if the ef-
fect is clinically relevant or negligible remains unknown
(or at best only based on the raw sample effect size).
In this case, as the p-value is quite large, neither can
the null hypothesis of no effect be rejected, nor can
be said with certainty that there is indeed no effect in
the sense of confirming the null hypothesis, leaving the
clinician without any trace to proceed with but to col-
lect more data. Figure 1 in contrast shows an analysis
of the posterior of δ produced by the Gibbs sampler
for the Bayesian t-test. In it, the ROPE, δMPE and
PMP (δMPE) are used. The posterior distribution of δ
is given in the upper plot and shows that the posterior
mean is 0.149 and the posterior mode 0.156, that is,
the mean posterior effect size given the data is 0.149,
no effect discernible from zero. The 95% highest den-
sity interval ranges from 0.114 to 0.182, showing that
with 95% probability, there is no effect discernible from
δ = 0, given the data. Even when taking the 100% high-
est posterior density interval (HPD), this situation does
not change as indicated by the upper plot. The coloured
horizontal lines and vertical dotted lines represent the
boundaries of the different ROPEs according to Cohen
[5]. The lower plot shows the results of partitioning the
posterior mass of δ into the ROPEs for different effect
sizes, which are standardized as small, if δ ∈ [0.2, 0.5),
medium, if δ ∈ [0.5, 0.8) and large, if δ ∈ [0.8,∞) [5].
100% of this posterior probability mass lies inside the
5 The data and code including a full replication script for
all simulations and figures presented in the paper is available
at https://osf.io/cvwr5/
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Fig. 1 Posterior distribution of the effect size δ and analysis
for the kitchen roll RCT of [30] via δMPE and PMP (δMPE)
ROPE (−0.2, 0.2) of no effect. So δMPE = 0.149 indi-
cates that no effect discernible from zero is apparent,
and the posterior mass percentage PMP (δMPE) = 1
(or 100%) shows that the estimate δMPE is trustwor-
thy, as the entire posterior probability mass is located
inside the ROPE (−0.2, 0.2) of no effect (also indicated
by the upper plot). Based on this analysis, one can con-
clude that given the data, it is highly probable, that
there exists no effect. The method provides more in-
sight than the information a p-value is giving: In the
example, the p-value cannot reject the null hypothe-
sis H0 : δ = 0 and neither can the null hypothesis be
confirmed. Even if the p-value would have been sig-
nificant, this means only that the result will unlikely
have happened by chance under the null hypothesis.
The non-significant p-value of 0.4542 in this case al-
lows not to accept the null hypothesis of no effect. The
proposed procedure in contrast does. Note also that a
Bayes factor would have to be combined with estima-
tion to yield the same information, and a Bayes fac-
tor alone of course would not have provided this in-
formation. In the example, the Bayes factor BF10 of
H1 : δ 6= 0 against H0 : δ = 0 is BF10 = 5.015 when
using the recommended wide Cauchy C(0, 1) prior of
Rouder et al. [28], which indicates only moderate evi-
dence for the null hypothesis H0 : δ = 0 according to
Van Doorn et al. [7]. This is in sharp contrast to the
PMP (δMPE) value of 100%, which strongly suggests
that the null hypothesis H0 : δ = 0 is confirmed. The
posterior in figure 1 is obtained by the Gibbs sampler
given in Corollary 1.
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3 Simulation study
Primary interest now lies in the ability to correctly es-
timate different sizes of effects via the combination of
the derived t-test, δMPE and PMP (δMPE). The effect
size ROPEs are oriented at the standard effect sizes of
Cohen [5], where an effect is categorized as small, if δ ∈
[0.2, 0.5) or δ ∈ (−0.5,−0.2], medium, if δ ∈ [0.5, 0.8]
or δ ∈ (−0.8,−0.5] and large, if δ ≥ 0.8 or δ ≤ −0.8.
Secondary interest lies in analysing if the Gibbs sampler
achieves better performance regarding the type I and II
error compared with Welch’s t-test, the standard NHST
solution.6 The plan of the study is as follows: If there
is indeed an effect, the Gibbs sampler should lead to a
posterior distribution of δ which lies outside the ROPE
(−0.2, 0.2), which is equivalent to the rejection of the
null hypothesis H0 : δ = 0. The precise estimation of
the size of an effect is a second task, one more demand-
ing than the sole rejection of H0 : δ = 0. If the sam-
pler correctly rejects the null hypothesis, because the
posteriors concentrate in the set (−∞,−0.2]∪ [0.2,∞),
this indicates that it makes no type II error and sub-
sequently achieves a power of nearly 100%. Of course,
this will depend on the sample sizes in both groups.
If additionally, the 95%-credible intervals of the poste-
riors concentrate in the set {(−0.5,−0.2] ∪ [0.2, 0.5)},
then the Gibbs sampler is also consistent for small ef-
fect sizes, again depending on the sample size. The
same rationale applies for medium effect sizes and the
ROPE {(−0.8, 0.5]∪ [0.5, 0.8)} and for large effect sizes
and the ROPE {(−∞, 0.8]∪ [0.8,∞)}. Therefore, three
two-component Gaussian mixtures have been fixed in
advance, each representing one of the three effect sizes.
For the small effect, the first component isN (2.89, 1.84)
and the second component N (3.5, 1.56), resulting in a
effect size of δ = (2.89 − 3.5)/
√
((1.562 + 1.842)/2) =
−0.35. For a medium effect, the first and second group
are simulated as N (254.08, 2.36) and N (255.84, 3.04),
yielding a true effect size of
δ =
(255.84− 254.08)√
((3.042 + 2.362)/2)
= 0.6467 ≈ 0.65
For the large effect, the first and second group are sim-
ulated as N (15.01, 3.42) and N (19.91, 5.82), yielding a
true effect size of
δ =
(19.91− 15.01)√
((5.82 + 3.42)/2)
= 1.03
In each of the three effect size scenarios, 100 datasets
of the corresponding two-component mixture were sim-
ulated for different sample sizes and the Gibbs sampler
6 We do not compare the type I error rate with Bayes fac-
tors, as these error types are formally not defined for the
Bayes factor.
was run for each of the 100 datasets for 10000 itera-
tions, using a burnin of 5000. δMPE , the ESR and the
ROPE criterion together with α-acceptance are applied,
that is, the hypothesis H stating a small, medium or
large effect size is α-accepted if the 95%-HPD lies com-
pletely inside the corresponding ROPE {(−0.5,−0.2]∪
[0.2, 0.5)}, {(−0.8,−0.5] ∪ [0.5, 0.8)} or {(−∞,−0.8] ∪
[0.8,∞)}. The recommended wide prior was used for all
simulations, which is detailed later in the prior sensitiv-
ity analysis. In total, the Gibbs sampler should stabilize
around the true effect size δ.7
3.1 Results
The upper row of Fig. 2 shows the results for small effect
sizes. The two left plots show the results for n = 100
and n = 200 observations in each group. It is clear that
the 95%-HPDs in both cases fluctuate strongly, indi-
cating that anything from no effect to a medium effect
is possible. The two right plots of the upper row show
the results when increasing to n = 300 and n = 700
observations per group. The 95%-HPDs get narrower
and stabilize inside the ROPE. While for n = 300 there
are still some outliers, for n = 700 all HPDs have con-
centrated inside the ROPE of a small effect – that is
PMP (δMPE) = 1 (100%) for all iterations – and the
estimates δMPE (blue points) have already converged
closely to the true effect size indicated by the solid black
line. The necessary sample size for this precision is not
small, but a small effect requires a large sample size to
be detected.
The middle row of Fig. 2 shows the results for medium
effect sizes. The two left plots in it show the result
for n = 100 and n = 200 observations in each group
for a medium effect size. Increasing the sample size to
n = 400 and n = 600 leads to the results shown in the
two right plots. These figures show that even for sam-
ple sizes of n = 100 in both groups, no 95% HPD lies
completely inside the ROPE (−0.2, 0.2) around δ0 = 0
of no effect, indicating that while the size of the effect
may still not be estimated accurately, a null hypothesis
of no effect δ0 = 0 could always be rejected when using
sample sizes of at least n = 100 in each group and the
underlying effect has medium size. When it comes to
precisely estimating the size of the effect, larger sample
sizes similar to those needed to detect small effect sizes
are necessary, as shown by the right plots of the second
row.
The lower row of Fig. 2 shows the results for large
effect sizes. About n = 50 observations in each group
7 Note, that here balanced groups are treated, but unbal-
anced groups could also easily be treated by setting N1(S)
and N2(S) accordingly, as described above.
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Fig. 2 Posterior Means δMPE and 95% credible-intervals for δMPE for 100 datasets consisting of sample sizes 2n, with n
observations in each group; dotted lines represent the ROPE boundaries; upper row : Small effect size; middle row : Medium
effect size; lower row : Large effect size
suffice to produce δMPE and PMP (δMPE) which es-
timate small to large effects, and thereby reject a null
hypothesis of no effect, while about n = 150 to n = 200
seem reasonable to precisely estimate a large effect size.
When using δMPE (blue points) as an estimator for δ,
sample sizes of n = 200 produce an estimate close to the
true effect size, which in this case was δ0 = 1.030723.
3.2 Controlling the type I error rate
In frequentist NHST, the Neyman-Pearson theory aims
at controlling the type I error rate α, which is the prob-
ability to reject the null hypothesis H0 falsely, when
indeed it is correct. In the setting of the two-sample
Bayesian t-test this equals the rejection of H0 : δ = 0
although the true effect size is δ0 = 0. Following Cohen
[5], an effect is considered small if the effect size is at
least |δ| ≥ 0.2, so effect sizes in the interval (−0.2, 0.2)
can be considered as noise, or practically equivalent to
zero. Therefore, a ROPE of (−0.2, 0.2) is set around
the null value δ0 = 0 to compare the type I error rate
of the proposed method against the standard frequen-
tist NHST solution, Welch’s t-test. Again 100 datasets
of different sample sizes are simulated where the true
effect size δ0 is set to zero. The Gibbs sampler should
produce a posterior distribution of δ which concentrates
inside the ROPE, so that the null hypothesis H : δ0 = 0
is α-accepted for α = 0.95, see definition 4. If the 95%-
HPD interval lies (entirely) outside the ROPE, this
equals α-rejection for α = 0.95, or in frequentist terms
the rejection of the null hypothesis H0 : δ0 = 0 of no
effect and therefore the commitment of a type I error.
The following two definitions formalize the type I and
II error building on the concept of α-rejection:
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Definition 6 (α type I error) An α type I error hap-
pens if the true parameter value δ0 ∈ H , with H ⊂ R
for a ROPE R ⊂ Θ, but H is α-rejected for α.
Definition 7 (α type II error) An α type II error
happens if the true parameter value δ0 /∈ H and δ0 /∈ R,
with H ⊂ R for a ROPE R ⊂ Θ, but H is α-accepted
for α.
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Fig. 3 Posterior means δMPE and 95% credible-intervals
for δ for 100 datasets consisting of different sample sizes 2n,
with n observations from a N (148.3, 1.34) distribution and n
observations from a N (148.3, 2.04) distribution; dotted lines
represent the ROPE (−0.2, 0.2) of no effect size around δ = 0;
posterior distributions are based on 10000 iterations of the
Gibbs sampler with a burnin of 5000 iterations
The left plot in figure 3 shows the results of 100 datasets
of size n = 50 in each group. The first group was
simulated as N (148.3, 1.34), and the second group as
N (148.3, 2.03). The true effect size is
δ0 =
µ2 − µ1√
(σ21 + σ
2
2)/2
= 0
The blue points represent δMPE and the blue dotted
lines the 95%-HPDs of the posterior of δ. While the es-
timates fluctuate strongly for n = 50, increasing sample
size in each group successively to n = 200 as shown by
the progression of the plots from left to right shows that
false-positive results – α type I errors with α = .95 –
get completely eliminated for sufficiently large sample
size. The right plot with sample size n = 300 shows
that no α type I error with α = .95 occurs anymore.
Also, δMPE stabilizes around the true value δ0 = 0 of
no effect, indicating its convergence to the true effect
size δ.
The simulations show that the α type I error rate
converges to zero when the sample size is increased.
The number of credible intervals which lie partly inside
and partly outside the ROPE decreases to zero. In con-
trast, p-values are uniformly distributed under the null
hypothesis, so that no matter what size the samples in
both groups are, in the long-run one will still obtain
α% (most often 5%) type I errors. Conducting Welch’s
t-tests will thus inevitably lead to a type I error rate of
5%, if the test level is set to α = .05. If the sample size
is at least n = 200 in each group, the proposed Bayesian
t-test together with δMPE and PMP (δMPE) performs
better with respect to control the α type I error rate.
From a theoretical perspective, it is of course of in-
terest for which values of α this fact does hold, and
indeed, using the two generalized types of type I and II
errors, it can also be shown that the number of type I
(type II) errors converges to zero for any α 6= 0, when
a correct (incorrect) ROPE is chosen:
Theorem 3 For the Bayesian two-sample t-test model,
the probability of making an α type I error for any α 6=
0 converges to zero for any correct ROPE R around
the hypothesis H which makes a statement about the
unknown parameter δ. Also, the probability of making a
α type II error for any α 6= 0 converges to zero for any
incorrect ROPE R.
A proof is given in Appendix A.5. The implications of
Theorem 3 are that if a correct ROPE R is chosen,
then eventually the probability of making a α type I
error will become zero. Thus, when the ROPE R in-
cludes the true parameter δ0, eventually the hypothesis
H will be α-accepted for α = 1, that is, accepted. If on
the other hand an incorrect ROPE is selected, which
does not include the true parameter δ0, then eventually
the probability of making a α type II error – that is,
accepting H although δ0 /∈ H – will become zero.
3.3 Prior sensitivity analysis
Section 2.3 detailed the independence prior used in the
model, and of specific interest is of course the influ-
ence of this prior on the results produced by the pro-
cedure. Therefore, three different hyperparameter set-
tings were selected to resemble a wide, medium and nar-
row prior, where the shrinkage effect on the standard
deviations σ2k, k = 1, 2 caused by the inverse Gamma
prior IG(c0, C0) on σ
2
k increases with the prior get-
ting narrower (that is, σ2i is shrunken towards zero).
The same applies for the normal prior N (b0, B0) on
the means µk, k = 1, 2. The following hyperparameters
were chosen for the three different settings: For the wide
prior, b0 := x¯ and B0 := 10·s
2(x) where x¯ and s2(x) are
the complete sample mean and variance. c0 and C0 were
selected as both 0.01 for the wide prior, implying fatter
tails of the inverse Gamma prior than in the medium or
narrow prior. For the medium prior, B0 was decreased
to 5 · s2(x), and c0 and C0 decreased to 0.1 both. For
the narrow prior finally, B0 := s
2(x) and c0 = C0 = 1,
which is the most informative of all three priors.
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Subsequently, 100 datasets with n = 100 obser-
vations in each group were simulated, where the first
group was generated asN (0, 1) and the second asN (1, 1).
The Gibbs sampler was run for 10000 iterations with a
burn-in of 5000 once for each prior on each dataset. Fig.
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Fig. 4 Prior sensitivity analysis for the N (b0, B0) prior on
the means µk and inverse Gamma prior IG(c0, C0) on the
variances σ2k, k = 1, 2 for 100 datasets with first group simu-
lated as N (0, 1) and the second as N (1, 1)
4 shows the results of the simulations. Here, the result-
ing posterior densities of δMPE are overlayed in figure
4, and it becomes clear that the wide and medium prior
do result in barely differing posteriors. When using the
narrow prior the shrinkage moves the posterior slightly
towards smaller values of δ.
The lower plot in Fig. 4 additionally shows the pos-
terior distributions of differences between means ob-
tained from the three priors: The left hand plot shows
the posterior distribution of differences between δMPE
obtained via a wide and a medium prior. The middle
plot shows the posterior distribution of differences be-
tween δMPE obtained via a wide and a narrow prior,
and the right hand plot the posterior distribution of
differences between δMPE obtained via a medium and
a narrow prior. The results show that in all cases the
differences are of tiny magnitude, indicating that the
proposed t-test is quite robust to the prior hyperparam-
eters selected. Of course, it can happen that δMPE will
be drawn towards smaller values when switching from
the wide to the narrow prior, but the posterior mass
percentage supporting a large effect will not vary much
as shown by the nearly identical resulting posterior den-
sities in figure 4, which is a strength of the continuous
quantification through PMP (δMPE). Based on the sen-
sitivity analysis all three hyperparameter settings differ
only slightly, and therefore the wide prior seems suit-
able for most applications, as it places itself between
the other two priors.
4 Discussion
In this paper, an estimation oriented alternative to ex-
isting Bayesian t-tests was introduced. Following the
proposal of a shift from hypothesis testing to estimation
under uncertainty, a Bayesian two-sample t-test was de-
rived for inference on the effect size δ, which is the quan-
tity of interest in most biomedical research. Also, the di-
chotomy of the ROPE decision rule of Kruschke & Lid-
dell [22] was resolved by introducing the mean probable
effect size δMPE as an estimator of δ, combined with the
posterior mass percentage PMP (δMPE), a continuous
measure which quantifies the support for the evidence
suggested by δMPE .
Theoretical results showed that the use of the pro-
posed method leads to a consistent estimation proce-
dure which shifts from hypothesis testing to estimation
under uncertainty. Also, theoretical results showed that
under any correct ROPE R, the number of introduced
α type I errors converges to zero a.s. under the law
determined by the prior pi on δ, while under any in-
correct ROPE (which means the ROPE picked by the
researcher does not cover the true parameter value δ0),
the number of introduced α type II errors converges to
zero a.s. under the law determined by the prior pi on δ.
Together, these properties and the introduced concept
of α-rejection make the proposed method an attrac-
tive alternative to existing solutions via p-values or the
Bayes factor.
One important limitation of the approach is that
the results depend on the chosen priors for µi and σi.
Although quite robust, especially the choice of the in-
verse Gamma prior for the variances may be questioned.
While it is beyond the scope of this paper to perform a
sensitivity analysis using different priors for the vari-
ances, one remedy which allows changing the priors
would be to switch to different sampling techniques, for
example Hamiltonian Monte Carlo in Stan [4]. Also, the
speed of convergence to entire elimination of type I er-
rors may be slow, although the simulation results are
promising.
The proposed method therefore may be helpful in
improving the reproducibility in biomedical research,
especially by reducing the number of false-positive re-
sults, which is one of the biggest problems of the medi-
cal sciences, see McElreath and Smaldino [24]. Finally,
it should be noted that both Bayes factors as well as
p-values are reasonable tools when hypothesis testing is
the goal, see also the recent results of Kelter [19]. The
proposed method is not intended to be a replacement
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of these tools, but as a complementary tool for cases
in which hypothesis testing is not desired but effect
size estimation under uncertainty is more important.
Therefore, the main advantage may be seen in the shift
towards effect size estimation. Future work could ex-
tend the model to more than two groups, leading to an
equivalent of the ANOVA, use more robust component
distributions like t-distributions, or derive the poste-
rior under different priors on the mixture components
parameters.
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Appendix
A.1. Derivation of the single-block Gibbs sampler
This supplementary material provides the derivation of
the joint posterior and full conditionals for the single-
block Gibbs sampler.
Bayesian parameter estimation for known allocations
In this section, for the setting when the Allocations
S are known the posterior distribution of µk, σ
2
k given
the complete data S, y are derived, see also [10]. As
already mentioned above, the weights (η1, ..., ηK) are
known in this case because for every observation yi ∈
(y1, ..., yN ) it is known to which group yi belongs, that
is, the quantities Si = k, k ∈ {1, ...K} are available for
all i ∈ {1, ..., N}.
In the setting of a t-test between two groups with
equal sample sizes n1 = n2 and n1 + n2 = N , the be-
longing of an observation yi to its group normally is
known for all observations i ∈ {1, ..., N}. The underly-
ing data generating process therefore can be assumed to
consist of a mixture of K = 2 components with weights
η1 = η2 = 0.5. This makes inference in the mixture
model much easier compared to the case when both the
weights (η1, ...ηK) as well as the component parameters
(µ1, ..., µK) and (σ
2
1 , ..., σ
2
K) are unknown.
To conduct inference about the unknown param-
eters, the necessary group-specific quantities are the
number Nk(S) of observations in group k, the within-
group variance s2y,k(S) and the group mean y¯k(S):
Nk(S) = |{i : Si = k}|
y¯k =
1
Nk(S)
∑
i:Si=k
yi
s2y,k(S) =
1
Nk(S)
∑
i:Si=k
(yi − y¯k(S))
2
where | · | denotes the cardinality of a set. These quanti-
ties depend on S, so the classification of the observation
yi to the component Si = k needs to be available. When
Si = k for an observation yi holds, then the observa-
tional model for observation yi is N (µk, σ2k) and yi con-
tributes to the complete-data likelihood p(y|µ, σ2, S) by
a factor of
1√
2piσ2k
exp
(
−
1
2σ2k
(yi − µk)
2
)
Taking into account all observations y1, ..., yN , the com-
pletedata likelihood function can be written as
p(y|µ, σ2, S) =
K∏
k=1
∏
i:Si=k
(
1
2piσ2k
)Nk(S)/2
· exp(−
1
2
∑
i:Si=k
(yi − µk)2
σ2k
)
The complete-data likelihood is a product of K compo-
nents, of which each summarizes the information about
the i-th group, i ∈ {1, ...,K}. These K factors are then
combined in a Bayesian analysis with a prior. While the
ultimate interest lies in the posterior of both µk, σ
2
k, we
consider first two different cases, which will eventually
lead to the solution of the joint posterior for µk and σ
2
k.
In the first case, when the variance σ2k is fixed, the
complete-data likelihood function as a function of µ is
the kernel of a univariate normal distribution. Choos-
ing a N (b0, B0)-distribution as a conjugate prior, the
posterior density of µk given σ
2
k and the Nk(S) obser-
vations in group k can be derived as
p(µk|σ
2
k, S, y) ∝ p(y|µk, σ
2
k, S) · p(µk, σ
2
k, S) (1)
(1)
= p(y|µk, σ
2
k, S) · p(µk) (2)
= (
1
2piσ2k
)Nk(S)/2 (3)
· exp(−
1
2
∑
i:Si=k
(yi − µk)
2
σ2k
) (4)
·
1
2piB0
exp(−
1
2
(µk − b0)2
B0
) (5)
where in (1) the fact that σ2k is assumed to be given and
the allocations S are known constants, too, was used.
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In general, for a sample of size n from a N (µ, σ) dis-
tribution with known variance σ2, a standard Bayesian
analysis, see e.g. [16, p. 181], yields, that the likelihood
L(µ) ∝ exp
(
−
n
2σ2
(µ− x¯)2
)
when combined with a prior µ ∼ N (ν, τ2) leads to the
posterior
µ|x ∼ N
((
n
σ2
+
1
τ2
)
−1
·
(nx¯
σ2
+
ν
τ2
)
,
(
n
σ2
+
1
τ2
)
−1
)
(6)
Substituting ν = b0 and τ
2 = B0 for the prior of µ as
well as µk for µ and σ
2
k for σ
2 in the likelihood, the
posterior p(µk|σ2k, S, y) in equation 1 becomes
p(µk|σ
2
k, S, y) ∼ N [
(
Nk(S)
σ2k
+
1
B0
)
−1
(7)
·
(
Nk(S)y¯k(S)
σ2k
+
b0
B0
)
,
(
Nk(S)
σ2k
+
1
B0
)
−1
]
By equation 7, the posterior can be written as
µk|σ
2
k, S, y ∼ N (bk(S), Bk(S))
with
Bk(S)
−1 = B−10 + σ
−2
k Nk(S) (8)
bk(S) = Bk(S)(σ
−2
k Nk(S)y¯k(S) +B
−1
0 b0) (9)
where for an empty group k the term Nk(S)y¯k(S) is
defined as zero.
On the other hand, if the mean µk is regarded as fixed,
the complete-data likelihood as a function of σ2k is the
kernel of an inverse Gamma density. Choosing the con-
jugate inverse Gamma prior σ2k ∼ IG(c0, C0), a stan-
dard Bayesian analysis – for details, see for example
[16, p. 181] – yields the posterior of σ2k|µk, S, y as
p(σ2k|µk, S, y) ∼ IG(ck(S), Ck(S)) (10)
with
ck(S) = c0 +
1
2
Nk(S) (11)
Ck(S) = C0 +
1
2
∑
i:Si=k
(yi − µk)
2 (12)
The case of interest here is when both µk and σ
2
k are
unknown, and in this case a closed-form solution for
the joint posterior p(µk, σ
2
k|S, y) does exist only under
specific conditions. That is, the prior variance of the
mean of group k, µk, must depend on σ
2
k through the
relation B0,k =
σ2k
N0
, where N0 is a newly introduced
hyperparameter in the prior of µk, that is, the prior
µk ∼ N (b0, B0) then becomes µk ∼ N (b0, σ2k/N0). The
joint posterior now can be rewritten as
p(µ, σ2|S, y) = p(µ1, ..., µK , σ
2
1 , ..., σ
2
K |S, y) (13)
(1)
=
K∏
k=1
p(µk, σ
2
k|S, y)
(2)
=
K∏
k=1
p(µk|σ
2
k, S, y)︸ ︷︷ ︸
=:(A)
· p(σ2k|S, y)︸ ︷︷ ︸
:=(B)
(14)
where (1) follows from the fact that the group parame-
ters µk, σ
2
k are assumed to be independent across groups
and (2) follows from factorising the joint posterior as
p(µk, σ
2
k|S, y) =
p(µk, σ
2
k|S, y) · p(σ
2
k|S, y)
p(σ2k|S, y)
= p(µk|σ
2
k, S, y) · p(σ
2
k|S, y)
As the factors (A) and (B) in equation 13 were already
derived in equation 7 as well as equation 10 with corre-
sponding parameters in equations 8, 9 and equations 11,
12 for arbitrary k, the factor (A) of the posterior equa-
tion 13 is normal-distributed N (bk(S), Bk(S)) with pa-
rameters
Bk(S)
(1)
=
1
B−10 + σ
−2
k Nk(S)
(2)
=
1
σ−2k N0 + σ
−2
k Nk(S)
(15)
=
1
N0 +Nk(S)
σ2k (16)
and
bk(S)
(3)
= Bk(S)(σ
−2
k Nk(S)y¯k(S) +B
−1
0 b0) (17)
(4)
= Bk(S)(σ
−2
k Nk(S)y¯k(S) +
N0
σ2k
b0) (18)
(5)
=
1
N0 +Nk(S)
σ2k(σ
−2
k Nk(S)y¯k(S) +
N0
σ2k
b0)
(19)
=
Nk(S)y¯k(S) +N0b0
N0 +Nk(S)
(20)
=
N0
Nk(S) +N0
b0 +
Nk(S)
Nk(S) +N0
y¯k(S) (21)
where in (1) Bk(S)
−1 = B−10 +σ
−2
k Nk(S) from equation
8 was used and in (2) the relation B0,k =
σ2k
N0
, where N0
is the newly introduced hyperparameter. In (3), equa-
tion 9 was used, in (4) again the relation B0,k =
σ2k
N0
, in
(5) the right-hand side of equation 15 was substituted
for Bk(S) in equation 18.
The remaining term (B) of equation 13 is the marginal
posterior of σ2k, that is∫
p(σ2k|µk, S, y)dµk
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and by integrating out µk, a standard Bayesian analysis
shows that the marginal posterior of σ2k is distributed
as inverse Gamma IG(ck(S), Ck(S)), where ck(S) is al-
ready given in equation 11, and the parameter Ck(S)
in equation 12 changes to
Ck(S) =
C0 +
1
2
(
Nk(S)s
2
y,k(S) +
Nk(S)N0
Nk(S) +N0
(y¯k(S)− b0)
2
)
This is, because by combining an inverse-gamma prior
with the normal likelihood with known mean yields an
inverse-gamma posterior as shown above and marginal-
ising this posterior for the variance yields exactly an-
other inverse-gamma distribution with different param-
eters. Details can be found in [16].
Application to the two-sample t-test – Derivation of the
marginal and joint posterior distributions
In the case of the two-sample t-test, the general deriva-
tions above can be specified more precisely. For two
groups, the mixture can be interpreted as a data gen-
erating process consisting of K = 2 components. The
weights η1 and η2 are both equal to 1/2 for equally sized
groups, that is, N = n1 + n2 with n1 being the sample
size of group one and n2 the sample size of group two
and n1 = n2.
Taking into account all observations y1, ..., yN , the com-
plete data likelihood function can be written as
p(y|µ, σ2, S) =
2∏
k=1
∏
i:Si=k
(
1
2piσ2k
)Nk(S)/2
· exp(−
1
2
∑
i:Si=k
(yi − µk)2
σ2k
)
=
∏
i:Si=1
(
1
2piσ21
)N1(S)/2
· exp(−
1
2
∑
i:Si=1
(yi − µ1)2
σ21
)
·
∏
i:Si=2
(
1
2piσ22
)N2(S)/2
· exp(−
1
2
∑
i:Si=2
(yi − µ2)2
σ22
)
where N1(S) = N2(S) = N/2.
The posteriors p(µk|σ2k, S, y) for k = 1, 2 in equation 1
then are N (bk(S), Bk(S))-distributed with
Bk(S) =
1
N0 +Nk(S)
σ2k (22)
bk(S) =
N0
Nk(S) +N0
b0 +
Nk(S)
Nk(S) +N0
y¯k(S) (23)
where also N1(S) = N2(S) = N/2 are half of total sam-
ple size and y¯k(S) is the mean of group k = 1, 2. After
choosing the conjugate prior µk ∼ N (b0, B0), these pos-
teriors can be computed.
The posteriors
σ2k|µk, S, y ∼ IG(ck(S), Ck(S))
with
ck(S) = c0 +
1
2
Nk(S) (24)
Ck(S) = C0 +
1
2
∑
i:Si=k
(yi − µk)
2 (25)
for k = 1, 2 become
σ21 |µ1, S, y ∼ G
−1(c0 +
1
2
N1(S), C0 +
1
2
∑
i:Si=1
(yi − µ1)
2)
σ22 |µ2, S, y ∼ G
−1(c0 +
1
2
N2(S), C0 +
1
2
∑
i:Si=2
(yi − µ2)
2)
and again, after selecting a conjugate inverse-gamma
prior σ2k ∼ IG(c0, C0) for k = 1, 2, these posteriors are
also completely determined.
The necessary marginal posteriors for σ2k for k = 1, 2
are then obtained, following the derivations in the above
section, as
p(σ21 |S, y) ∼ IG(c0 +
1
2
N1(S), C0+
1
2
(
N1(S)s
2
y,1(S) +
N1(S)N0
N1(S) +N0
(y¯1(S)− b0)
2
)
)
and
p(σ22 |S, y) ∼ IG(c0 +
1
2
N2(S), C0
+
1
2
(
N2(S)s
2
y,2(S) +
N2(S)N0
N2(S) +N0
(y¯2(S)− b0)
2
)
)
These marginal posteriors are completely determined,
once c0, C0 is given by the selected prior IG(c0, C0) and
the group variances s2y,1(S) and s
2
y,2(S) are calculated.
Again here, N1(S) = N2(S) = N/2 due to equal sizes
of both groups, and the y¯1(S) and y¯2(S) are the means
of the two groups.
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The joint posterior, which is the ultimate quantity of
interest, then can be rewritten as
p(µ, σ2|S, y) = p(µ1, µ2, σ
2
1 , σ
2
2 |S, y) =
2∏
k=1
p(µk, σ
2
k|S, y)
=
2∏
k=1
p(µk|σ
2
k, S, y)︸ ︷︷ ︸
=:(A)
· p(σ2k|S, y)︸ ︷︷ ︸
:=(B)
= p(µ1|σ
2
1 , S, y)p(σ
2
1 |S, y)
· p(µ2|σ
2
2 , S, y)p(σ
2
2 |S, y)
= N (b1(S), B1(S)) · IG(c1(S), C1(S))
· N (b2(S), B2(S)) · IG(c2(S), C2(S))
A.2. Proof of Theorem 1 – Derivation of the full con-
ditionals for the single-block Gibbs sampler
Proof To make Gibbs sampling possible, the full condi-
tionals of
p(µ, σ2|S, y) = p(µ1, µ2, σ
2
1 , σ
2
2 |S, y)
need to be derived. We start with p(µ1|µ2, σ21 , σ
2
2 , S, y):
p(µ1|µ2, σ
2
1 , σ
2
2 , S, y) =
p(µ1, µ2, σ
2
1 , σ
2
2 , S, y)
p(µ2, σ21 , σ
2
2 , S, y)
=
p(µ1, µ2, σ
2
1 , σ
2
2 |S, y)✘✘
✘p(S, y)
p(µ2, σ21 , σ
2
2 |S, y)✘✘
✘p(S, y)
(1)
=
∏K
k=1 p(µk|σ
2
k, S, y)p(σ
2
k|S, y)
p(µ2, σ22 |S, y)p(σ
2
1 |S, y)
(2)
=
p(µ1|σ21 , S, y)✘✘✘
✘✘p(σ21 |S, y)✭✭✭
✭
✭
✭
p(µ2|σ22 , S, y)✘✘✘
✘✘p(σ22 |S, y)
✭
✭
✭
✭
✭✭p(µ2|σ22 , S, y)✘✘✘
✘✘p(σ22 |S, y)✘✘✘
✘✘p(σ21 |S, y)
= p(µ1|σ
2
1 , S, y)
where in (1) the independence of σ21 and µ2, σ
2
2 was
used, so that p(µ2, σ
2
1 , σ
2
2 |S, y) = p(µ2, σ
2
2 |S, y)·p(σ
2
1 |S, y)
holds, and in (2) the factorization p(µ2, σ
2
2 |S, y) = p(µ2|σ
2
2 , S, y)·
p(σ22 |S, y) was used.
The full conditional of µ2 is given by p(µ2|µ1, σ21 , σ
2
2 , S, y),
which is derived as
p(µ2|µ1,σ
2
1 , σ
2
2 , S, y) =
p(µ2, µ1, σ
2
1 , σ
2
2 , S, y)
p(µ1, σ21 , σ
2
2 , S, y)
=
p(µ2, µ1, σ
2
1 , σ
2
2 |S, y)✘✘
✘p(S, y)
p(µ1, σ21 , σ
2
2 |S, y)✘✘
✘p(S, y)
=
∏K
k=1 p(µk|σ
2
k, S, y)p(σ
2
k|S, y)
p(µ1, σ21 |S, y)p(σ
2
2 |S, y)
=✭
✭
✭
✭
✭✭p(µ1|σ21 , S, y)✘✘✘
✘✘p(σ21 |S, y)p(µ2|σ
2
2 , S, y)✘✘✘
✘✘p(σ22 |S, y)
✭
✭
✭
✭
✭✭p(µ1|σ21 , S, y)✘✘✘
✘✘p(σ22 |S, y)✘✘✘
✘✘p(σ21 |S, y)
= p(µ2|σ
2
2 , S, y)
where the reasoning is the same as in the derivation of
the full conditional for µ1.
The full conditional of σ21 is p(σ
2
1 |µ1, µ2, σ
2
2 , S, y),
which is derived as:
p(σ21 |µ1, µ2, σ
2
2 , S, y) =
p(σ21 , µ1, µ2, σ
2
2 , S, y)
p(µ1, µ2, σ22 , S, y)
=
p(σ21 , µ1, µ2, σ
2
2 |S, y)✘✘
✘p(S, y)
p(µ1, µ2, σ22 |S, y)✘✘
✘p(S, y)
=
p(σ21 , µ1, µ2, σ
2
2 |S, y)
p(µ1, µ2, σ22 |S, y)
(1)
=
∏2
k=1 p(σ
2
k|µk, S, y) · p(µk|S, y)
p(µ1|S, y) · p(µ2, σ22 |S, y)
(2)
=
p(σ21 |µ1, S, y) · p(µ1|S, y) ·✭✭✭
✭
✭
✭
p(σ22 |µ2, S, y) ·✘✘✘
✘✘p(µ2|S, y)
p(µ1|S, y) ·✭✭✭✭
✭✭p(σ22 |µ2, S, y) ·✘✘✘
✘✘p(µ2|S, y)
=✘
✘
✘
✘✘p(µ1|S, y) · p(σ21 |µ1, S, y)
✘
✘
✘
✘✘p(µ1|S, y)
= p(σ21 |µ1, S, y)
where in (1) first the independence of parameters be-
tween both groups was used, that is, the independence
of µ1, σ
2
1 and µ2, σ
2
2 and second (as a special case of
this fact) the independence of µ1 and µ2, σ
2
2 was used.
Therefore, p(σ21 , µ1, µ2, σ
2
2 |S, y) =
∏2
k=1 p(σ
2
k|µk, S, y) ·
p(µk|S, y) holds and also p(µ1, µ2, σ22 |S, y) = p(µ1|S, y)·
p(µ2, σ
2
2 |S, y). In (2) the factorization p(µ2, σ
2
2 |S, y) =
p(σ22 |µ2, S, y) · p(µ2|S, y) was used.
The full conditional p(σ22 |µ1, µ2, σ
2
1 , S, y) of σ
2
2 is
similarly given by:
p(σ22 |µ1, µ2, σ
2
1 , S, y) =
p(σ21 , µ1, µ2, σ
2
2 , S, y)
p(µ1, µ2, σ21 , S, y)
=
p(σ21 , µ1, µ2, σ
2
2 |S, y)✘✘
✘p(S, y)
p(µ1, µ2, σ21 |S, y)✘✘
✘p(S, y)
=
p(σ21 , µ1, µ2, σ
2
2 |S, y)
p(µ1, µ2, σ21 |S, y)
(1)
=
∏2
k=1 p(σ
2
k|µk, S, y) · p(µk|S, y)
p(µ2|S, y) · p(µ1, σ21 |S, y)
(2)
= ✭
✭
✭
✭
✭✭p(σ21 |µ1, S, y) ·✘✘✘
✘✘p(µ1|S, y) · p(σ22 |µ2, S, y) · p(µ2|S, y)
p(µ2|S, y) ·✭✭✭✭
✭
✭
p(σ21 |µ1, S, y) ·✘✘✘
✘✘p(µ1|S, y)
=✘
✘
✘
✘✘p(µ2|S, y) · p(σ22 |µ2, S, y)
✘
✘
✘
✘✘p(µ2|S, y)
= p(σ22 |µ1, S, y)
where in (1) first the independence of parameters be-
tween both groups, that is, the independence of µ1, σ
2
1
and µ2, σ
2
2 and second (as a special case of this) the
independence of µ2 and µ1, σ
2
1 was used. Therefore,
p(σ21 , µ1, µ2, σ
2
2 |S, y) =
∏K
k=1 p(σ
2
k|µk, S, y) · p(µk|S, y)
holds and one also has p(µ1, µ2, σ
2
2 |S, y) = p(µ1|S, y) ·
p(µ2, σ
2
2 |S, y). In (2) the factorization p(µ1, σ
2
1 |S, y) =
p(σ21 |µ1, S, y)·p(µ1|S, y) was used. In total, the full con-
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ditionals therefore are derived as:
p(µ1|µ2, σ
2
1 , σ
2
2 , S, y) = p(µ1|σ
2
1 , S, y)
p(µ2|µ1, σ
2
1 , σ
2
2 , S, y) = p(µ2|σ
2
2 , S, y)
p(σ21 |µ1, µ2, σ
2
2 , S, y) = p(σ
2
1 |µ1, S, y)
p(σ22 |µ1, µ2, σ
2
1 , S, y) = p(σ
2
1 |µ1, S, y)
When using the independence prior, the full condition-
als are therefore given by
p(µ1|µ2, σ
2
1 , σ
2
2 , S, y) = p(µ1|σ
2
1 , S, y) ∼ N (b1(S), B1(S))
(26)
p(µ2|µ1, σ
2
1 , σ
2
2 , S, y) = p(µ2|σ
2
2 , S, y) ∼ N (b2(S), B2(S))
(27)
p(σ21 |µ1, µ2, σ
2
2 , S, y) = p(σ
2
1 |µ1, S, y) ∼ IG(c1(S), C1(S))
(28)
p(σ22 |µ1, µ2, σ
2
1 , S, y) = p(σ
2
1 |µ2, S, y) ∼ IG(c2(S), C2(S))
(29)
with b1(S), B1(S), b2(S), B2(S), c1(S), c2(S), C1(S) and
C2(S) as specified in the previous section in equations
(22), (23), (24) and (25), which completes the proof.
A.3. Proof of Corollary 1
Proof From standard MCMC theory, see e.g. [27], it is
clear that the full conditionals derived in Theorem 1 can
be used to construct a Gibbs sampler, by iteratively up-
dating each parameter via simulating step by step from
the full conditionals (26) to (29). Using (26) to (29),
this leads to the following Gibbs sampling algorithm:
1. Sample σ2k in each group k, k = 1, 2 from an inverse
Gamma distribution G−1(ck(S), Ck(S)) (which de-
pends on µk)
2. Sample µk in each group k, k = 1, 2, from a nor-
mal distribution N (bk(S), Bk(S)) (which depends
on σ2k)
where Bk(S), bk(S) and ck(S), Ck(S) are given by equa-
tions (22), (23), (24) and (25). The convergence to the
joint posterior p(µ1, µ2, σ
2
1 , σ
2
2 |S, y) then follows then
from standard MCMC theory, see [27].
A.4. Proof of Theorem 2
Proof In the case the ROPE Rj is correct, Rj includes
the true effect size δ0, so that δ0 ⊂ Rj . Estimation of
δ via δMPE is then consistent: A posterior distribution
pn is said to be consistent for the parameter δ0, if for
every neighbourhood U of δ0, pn(U)
a.s.
−−−−→
n→∞
1 almost
surely under the law determined by δ0. By Theorem 1
in [11] the consistency of the posterior follows for any
prior pi when choosing any ROPE U including the true
parameter δ0, except possibly on a set of pi-measure
zero. As a direct consequence one therefore obtains: If
the ROPE Rj 6= ∅ is correct and contains the true pa-
rameter δ0, any prior pi leads to a consistent posterior
for which pn(Rj)
a.s.
−−−−→
n→∞
1 almost surely under the law
determined by δ0 except possibly on a set of pi-measure
zero. This means that
PMP (δMPE) =
∫
Rj
f(θ|x)dθ
a.s.
−−−−→
n→∞
1
If on the other hand Rj is incorrect, then δ0 /∈ Rj .
Then there exists a neighbourhood N := (δ0−ε, δ0+ε)
for ε > 0 around δ0, so that N ∩ Rj = ∅. Then, as
pn(N)
a.s.
−−−−→
n→∞
1 almost surely under the law determined
by δ0 except possibly on a set of pi-measure zero, it
follows that on the complement N c, pn(N
c)
a.s.
−−−−→
n→∞
0
and because of Rj ⊂ N c also that pn(Rj)
a.s.
−−−−→
n→∞
0
almost surely under the law determined by δ0 except
possibly on a set of pi-measure zero. Thereby it follows
that
PMP (δMPE) =
∫
Rj
f(θ|x)dθ
a.s.
−−−−→
n→∞
0
A.5. Proof of Theorem 3
Proof An α type I error happens if the true parameter
value δ0 ∈ H , with H ⊂ R for a ROPE R ⊂ Θ, but H
is α-rejected for α. If any correct ROPE R is selected
around the hypothesis H ⊂ Θ which makes a statement
about the unknown parameter δ, then the true value
δ0 of δ is inside R, that is δ0 ⊂ R. Then, under any
prior pi on δ, the posterior pn(R)
a.s.
−−−−→
n→∞
1 except on
a set of pi-measure zero, compare [11]. Therefore, the
corresponding α% HPD interval Cα of f(δ|x) lies inside
R for n → ∞, too, that is: Cα ⊂ R, and by definition,
H is then α-accepted. As α was arbitrary, the above
holds in particular without loss of generality for α = 1,
and therefore, H is accepted always for n→∞ almost
surely under the law determined by pi for any correct
ROPE R around the hypothesis H . This in turn implies
thatH can only be α-rejected for α = 0 under the above
conditions.8
An α type II error happens if the true parameter
value δ0 /∈ H and δ /∈ R, with H ⊂ R for a ROPE
R ⊂ Θ, but H is α-accepted for α. If any incorrect
8 Note that α rejection of H for α = 0 is only stating
that zero percent of the HPD interval are located outside the
ROPE R around H, which means that the α% HPD lies fully
inside the ROPE. This in fact confirms H, being in agreement
with the intuition of no type I error occuring.
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ROPE R is selected around the hypothesis H ⊂ Θ
which makes a statement about the unknown parame-
ter δ, then the true value δ0 of δ is not inside R, that
is δ0 /∈ R. Then, under any prior pi on δ, the posterior
pn(R)
a.s.
−−−−→
n→∞
0 except on a set of pi-measure zero, com-
pare [11]. Therefore, the corresponding α% HPD inter-
val Cα of f(δ|x) lies not inside R for n → ∞, which
means Cα /∈ R, and by definition, H is then α-rejected.
As α was arbitrary, the above holds in particular for
α = 1, and therefore, H is rejected always for n → ∞
almost surely under the law determined by pi for any
incorrect ROPE R around the hypothesis H . This also
implies that H can only be α-accepted for α = 0 under
the above conditions.9
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